https://www.selleckchem.com/pr....oducts/oseltamivir-a
Epilepsy is defined as "drug-resistant" when existing anti-epileptic drugs (AED) are found to have minimal to no effect on patient's condition. Therefore the search and testing of new treatment strategies is warranted. This study focuses on the effects of autologous mesenchymal stem cells (MSC) in drug-resistant epilepsy patients within a Phase I/II open-label registered clinical trial NCT02497443. A total of 67 patients was included (29 males, 38 females, mean age 33±1.3 yo). The patients received either standard treatment wit